We have previously shown that transgenic mice co-expressing an active ALKF1174L mutation with MYCN via the tyrosine hydroxylase promoter potentiates neuroblastoma development characterized by earlier onset, higher penetrance and enhanced lethality (Berry et al., 2012). This evidence concerns the gene TH and neuroblastoma.